What is it about?
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Chest computed tomography (CT) plays an essential role in the evaluation of COVID-19. This retrospective study aims to determine and compare the pulmonary changes in Iraqi patients with COVID-19 disease across the first two weeks after onset of symptoms using computerized tomography (CT) scan.
Featured Image
Why is it important?
The type, extent, and distributions of pulmonary manifestations associated with COVID-19 infection are significantly different between the two groups who have been scanned in different stages of the disease.
Read the Original
This page is a summary of: Pulmonary ct manifestations of COVID-19: changes within 2 weeks duration from presentation, Egyptian Journal of Radiology and Nuclear Medicine, June 2020, Springer Science + Business Media,
DOI: 10.1186/s43055-020-00223-0.
You can read the full text:
Contributors
The following have contributed to this page
